Detalhe da pesquisa
1.
A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose.
Eur J Haematol
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711359
2.
Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
J Am Acad Dermatol
; 86(6): 1285-1292, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273458
3.
Application of the current diagnostic algorithm for early mycosis fungoides to a single center cohort: Identification of challenges and suggestions for modification.
J Cutan Pathol
; 49(9): 772-779, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445764
4.
Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response.
Br J Haematol
; 192(3): 484-493, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32519348
5.
Brentuximab vedotin in the treatment of CD30+ PTCL.
Blood
; 134(26): 2339-2345, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697814
6.
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
Ann Hematol
; 100(10): 2529-2539, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304287
7.
Response to topical corticosteroid monotherapy in mycosis fungoides.
J Am Acad Dermatol
; 84(3): 615-623, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32428610
8.
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes.
Biol Blood Marrow Transplant
; 26(10): 1861-1867, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32629157
9.
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.
Cancer
; 126(6): 1235-1242, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821549
10.
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.
Blood
; 131(8): 888-898, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29233821
11.
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies.
Blood
; 131(8): 877-887, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191916
12.
Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
Blood
; 131(7): 771-781, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29180399
13.
A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
J Am Acad Dermatol
; 83(1): 78-85, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32004646
14.
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
Lancet Oncol
; 20(8): 1160-1170, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253572
15.
Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters.
Biol Blood Marrow Transplant
; 25(9): e293-e297, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173899
16.
Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
Cancer Treat Res
; 176: 83-98, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30596214
17.
Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis.
J Am Acad Dermatol
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513830
18.
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Lancet Oncol
; 19(9): 1192-1204, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100375
19.
The rise of a new "great teacher".
Blood
; 138(3): 205-206, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292328
20.
Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.
Am J Hematol
; 93(11): 1318-1326, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30094870